Astra Plots Post-Covid Future With $39 Billion Alexion Deal

...an out. Read More: Big Pharma Grants License to Kill Drug Programs as Costs Surge But a takeover attempt from Pfizer Inc. that Soriot fended off six years ago taught the importance of scale. AstraZeneca made a preliminar...
Read Full Article